CareLit Fachartikel

Adjuvant Interferon Therapy for Renal Cell Carcinoma

Y. Aso, Y. Homma, Japanese Study Group of Interferon for Renal Cell Carcinoma · Aktuelle Urologie · 1996 · Heft S 1 · S. 9-12

Dokument
1067919
CareLit-ID
Jahr
1996
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Aktuelle Urologie
Autor:innen
Y. Aso, Y. Homma, Japanese Study Group of Interferon for Renal Cell Carcinoma
Ausgabe
Heft S 1 / 1996
Jahrgang 27
Seiten
9-12
Erschienen: 1996-04-01 00:00:00
ISSN
0001-7868
DOI
10.1055/s-2008-1055636

Zusammenfassung

Summary: The efficacy of adjuvant interferon therapy in radical nephrectomy is quite controversial. The author's group randomized 342 cases with histologically proven renal cell carcinoma (RCC) in Robson stages I and II into the adjuvant interferon group (group A) and the no-adjuvant group (group B) by the envelope method. The result showed no difference in recurrence free rates between the groups. Probably because of violation of the envelope method, there was a significant background difference especially in tumor size and pT. Therefore, multiple regression analysis following the Cox model was performed. The t…

Schlagworte

Interferon Renal cell carcinoma Adjuvant therapy Tumor Bias Aktuelle Urologie